Nina Hulin

Nina Hulin is an experienced professional in the pharmaceutical and clinical research fields, currently serving as Cheffe du pôle Pédiatrie, Essais cliniques précoces et Innovation thérapeutique at ANSM Agence nationale de sécurité du médicament et des produits de santé since May 2017. In this role, Nina leads initiatives within the Direction Europe et Innovation, focusing on early clinical trials and pediatric medicine, and is also involved in emergency situations and risk management as part of the CASAR. Previously, Nina held positions at Bayer as a Global Regulatory Affairs Intern in Oncology and at Alcon as a Quality Assurance Technician. Academic credentials include a Doctor of Pharmacy from Université de Lorraine, an MSc in Drug Development and International Registration from Paris-Sud University, and a short training in handling exceptional sanitary situations from EHESP.